Kookjeon Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	105,651	168,844	172,478	306,192	324,839	537,308
Market Cap Growth	-50.31%	-2.11%	-43.67%	-5.74%	-39.54%	-
Enterprise Value	116,687	189,611	178,557	319,290	284,635	-
Last Close Price	1957.00	3365.00	3515.00	6222.17	6590.26	10900.81
PE Ratio	-	-	99.34	63.47	36.30	133.06
PS Ratio	0.83	1.29	1.26	2.51	3.13	6.30
PB Ratio	0.98	1.76	1.77	3.14	3.52	6.46
P/TBV Ratio	1.00	1.78	1.80	3.22	3.60	6.50
P/FCF Ratio	23.34	22.53	82.14	-	-	-
P/OCF Ratio	12.51	15.92	17.31	-	-	176.63
EV/Sales Ratio	0.92	1.45	1.31	2.62	2.75	-
EV/EBITDA Ratio	22.35	71.19	32.63	33.11	57.72	-
EV/EBIT Ratio	-	-	486.92	49.05	81.60	-
EV/FCF Ratio	25.78	25.30	85.04	-	-	-
Debt / Equity Ratio	0.37	0.48	0.67	0.81	0.64	0.09
Debt / EBITDA Ratio	7.68	17.23	11.94	8.17	12.03	1.09
Debt / FCF Ratio	8.88	6.13	31.11	-	-	-
Net Debt / Equity Ratio	0.09	0.16	0.19	0.14	-0.39	-0.38
Net Debt / EBITDA Ratio	1.87	5.77	3.38	1.45	-7.22	-4.35
Net Debt / FCF Ratio	2.17	2.05	8.81	-0.31	1.22	4.26
Asset Turnover	0.64	0.67	0.62	0.58	0.68	-
Inventory Turnover	4.40	5.02	4.22	4.05	4.62	-
Quick Ratio	0.91	0.82	0.85	0.94	1.67	2.72
Current Ratio	1.32	1.13	1.19	1.24	2.02	3.52
Return on Equity (ROE)	-7.91%	-4.98%	0.55%	4.95%	10.12%	-
Return on Assets (ROA)	-0.00%	-0.82%	0.10%	1.93%	1.44%	-
Return on Invested Capital (ROIC)	-0.01%	-2.26%	0.20%	7.75%	5.15%	9.38%
Return on Capital Employed (ROCE)	0.00%	-2.30%	0.30%	5.20%	2.80%	7.20%
Earnings Yield	-7.43%	-2.55%	1.01%	1.58%	2.76%	0.75%
FCF Yield	4.28%	4.44%	1.22%	-14.46%	-9.02%	-1.37%
Payout Ratio	-	-	28.26%	-	5.48%	-
Buyback Yield / Dilution	-1.15%	-0.51%	-1.09%	4.23%	-16.16%	-